SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Abeona Therapeutics Inc. – ‘DEF 14A’ for 3/19/24

On:  Tuesday, 3/19/24, at 7:19am ET   ·   For:  3/19/24   ·   Accession #:  1493152-24-10421   ·   File #:  1-15771

Previous ‘DEF 14A’:  ‘DEF 14A’ on / for 4/13/23   ·   Latest ‘DEF 14A’:  This Filing   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/19/24  Abeona Therapeutics Inc.          DEF 14A     3/19/24    1:1.8M                                   M2 Compliance LLC/FA

Definitive Proxy Statement   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEF 14A     Definitive Proxy Statement                          HTML    738K 




        
Filing Submission 0001493152-24-010421 – SGML Text

Original SGML Text submitted by:  M2 Compliance LLC/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 1.9M                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20240319-071946	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20240319-071945	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20240319-071912	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001493152-24-010421
<TYPE>				DEF 14A
<PUBLIC-DOCUMENT-COUNT>		5
<PERIOD>			20240319
<FILING-DATE>			20240319
<DATE-OF-FILING-DATE-CHANGE>	20240319
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		ABEONA THERAPEUTICS INC.
<CIK>				0000318306
<ASSIGNED-SIC>			2834
<ORGANIZATION-NAME>		03 Life Sciences
<IRS-NUMBER>			830221517  83-0221517
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			DEF 14A
<ACT>				34
<FILE-NUMBER>			001-15771
<FILM-NUMBER>			24761084
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			6555 CARNEGIE AVE, 4TH FLOOR
<CITY>				CLEVELAND
<STATE>				OH
<ZIP>				44103
<PHONE>				646-813-4701
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			6555 CARNEGIE AVE, 4TH FLOOR
<CITY>				CLEVELAND
<STATE>				OH
<ZIP>				44103
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		PLASMATECH BIOPHARMACEUTICALS INC
<DATE-CHANGED>			20140922
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		ACCESS PHARMACEUTICALS INC
<DATE-CHANGED>			19960209
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		CHEMEX PHARMACEUTICALS INC
<DATE-CHANGED>			19920703
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>		DEF 14A
<SEQUENCE>	1
<FILENAME>	formdef14a.htm
<TEXT>
<HTML>
       Show <HTML>: 6,222 lines (widest: 1,534 characters) - 750K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	2  Not a Document/Exhibit
<FILENAME>	formdef14a_001.jpg
<TEXT>
       Show <TEXT>: 1,725 lines (Unix-to-Unix encoding) - 105K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	3  Not a Document/Exhibit
<FILENAME>	formdef14a_002.jpg
<TEXT>
       Show <TEXT>: 2,002 lines (Unix-to-Unix encoding) - 121K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	4  Not a Document/Exhibit
<FILENAME>	proxy_001.jpg
<TEXT>
       Show <TEXT>: 6,508 lines (Unix-to-Unix encoding) - 394K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	5  Not a Document/Exhibit
<FILENAME>	proxy_002.jpg
<TEXT>
       Show <TEXT>: 8,922 lines (Unix-to-Unix encoding) - 540K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0001493152-24-010421   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:25:06.4pm ET